Researchers discover new type of CRISPR gene scissors

Chase Beisel (left) and Oleg Dmytrenko.
(c) HIRI

Component of bacterial immune defense paralyzes infected cells and could advance molecular biology diagnostics.

It is an unexpected discovery by scientists at the Helmholtz Institute Würzburg in cooperation with Benson Hill, Inc. (Missouri) and Utah State University in the U.S.: They have found a nuclease, which they dubbed Cas12a2, that represents an entirely new type of CRISPR immune defense. Unlike any other previously known nuclease of the CRISPR-Cas immune system, the source of “gene scissors”, Cas12a2 destroys DNA to shut down an infected cell. The findings could lead to new CRISPR technologies for molecular biology diagnostics, among other applications, and were published today in the journal Nature.

Like humans, bacteria and archaea can be attacked by viruses. These microorganisms have developed their own immune defense strategies against their pathogens. Bacterial defenses, such as CRISPR-Cas systems, have diverse proteins and functions that help bacteria protect themselves against foreign invaders. The defense is based on a common mechanism: A CRISPR ribonucleic acid (crRNA), serving as a “guide RNA”, helps detect regions of a foreign genome, such as the DNA of a virus, for targeted cleavage. The CRISPR-associated (Cas) nuclease directed by a crRNA can cut its target like a pair of scissors: a strategy of nature that humans have harnessed in many technologies.

“Considering how well different nucleases have been translated into new and improved technologies, any discovery in this field could bring new benefits to society,” says Chase Beisel, describing a research motivation of his laboratory at the Würzburg Helmholtz Institute for RNA-based Infection Research (HIRI). The institute is a site of the Braunschweig Helmholtz Centre for Infection Research (HZI) in cooperation with the Julius-Maximilians-Universität (JMU) in Würzburg. Beisel initiated the current study on a specific set of CRISPR-Cas systems with Matthew Begemann at Benson Hill, Inc. (Missouri) and Ryan Jackson at Utah State University in the U.S. The results were published today in the renowned journal Nature and were accompanied by detailed structural analysis from a second team, also led by Ryan Jackson, and by David Taylor at University of Texas.

Unique from any other known CRISPR nuclease

“We were exploring CRISPR nucleases that were originally clumped with Cas12a, nucleases that defend bacteria by recognizing and cleaving invasive DNA. Once we identified more of them, we realized that they were different enough from Cas12a to warrant a deeper dive,” tells Oleg Dmytrenko, the first author of the study. “This exploration led us to discover that these nucleases, which we called Cas12a2, do something very different not only from Cas12a but also from any other known CRISPR nuclease.”

The crucial difference lies in the mechanism of their defense action. When Cas12a2 recognizes invasive RNA, the nuclease cleaves it but can also damage other RNA and DNA inside the cell, impairing its growth and limiting the spread of the infection. “In general, such defense strategies that abort the infection have been known in bacteria,” says HIRI postdoc Oleg Dmytrenko. “A few other CRISPR-Cas systems work in this way. However, a CRISPR-based defense mechanism that relies on a single nuclease to recognize the invader and degrade cellular DNA and RNA has not been observed before,” the scientist says.

The findings in detail

The protein sequence and architecture of Cas12a2 discriminate this nuclease from Cas12a. Activated by a protospacer-flanking sequence (PFS), Cas12a2 recognizes target RNAs that are complementary to its guide RNA. Targeting RNA triggers collateral nucleic acid cleavage that degrades RNA, single-stranded DNA, and double-stranded DNA. This activity leads to cell arrest, presumably by damaging DNA and RNA in the cell, which impairs growth. Cas12a2 can be used for molecular diagnostics and direct detection of RNA biomarkers, as demonstrated by proof-of-principle.

A destructive cleft

In further structural analysis of the nuclease by a second team that authored the companion paper in the same issue of Nature, Cas12a2 was shown to undergo major structural changes after binding to its RNA target at various stages of the immune response. This, in turn, leads to an exposed cleft in the nuclease that can shred any nucleic acid it encounters – be it RNA, single-stranded DNA or double-stranded DNA. The research also discovered ways to mutate Cas12a2 to alter the nucleic acid that the nuclease degrades after recognizing its RNA target. These specifics open up potentially broad technological applications for the future.

Funding:
The study was supported by funding from the European Research Council (ERC Consolidator Award to Chase Beisel), the German Federal Agency for Disruptive Innovation (SPRIND), the Pre-4D program of the Helmholtz Centre for Infection Research, and with funds from the National Institutes of Health and the Welch Foundation.

This press release is also available on our website: https://www.helmholtz-hzi.de/en/news-events/news/view/article/complete/forschend….

Helmholtz Institute for RNA-based Infection Research:
The Helmholtz Institute for RNA-based Infection Research (HIRI) is the first institution of its kind worldwide to combine ribonucleic acid (RNA) research with infection biology. Based on novel findings from its strong basic research program, the institute’s long-term goal is to develop innovative therapeutic approaches to better diagnose and treat human infections. HIRI is a site of the Braunschweig Helmholtz Centre for Infection Research (HZI) in cooperation with the Julius-Maximilians-Universität Würzburg (JMU) and is located on the Würzburg Medical Campus. More information at http://www.helmholtz-hiri.de.

Helmholtz Centre for Infection Research:
Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and its other sites in Germany are engaged in the study of bacterial and viral infections and the body’s defence mechanisms. They have a profound expertise in natural compound research and its exploitation as a valuable source for novel anti-infectives. As member of the Helmholtz Association and the German Center for Infection Research (DZIF) the HZI performs translational research laying the ground for the development of new treatments and vaccines against infectious diseases. http://www.helmholtz-hzi.de/en

Media Contact:
Dr Britta Grigull
Head of Communications
Helmholtz Institute for RNA-based Infection Research (HIRI)
Josef-Schneider-Str. 2 / D15
97080 Würzburg
Germany
+49 931 31 81801
britta.grigull@helmholtz-hiri.de

Originalpublikation:

1.)
Dmytrenko O, Neumann GC, Hallmark T, Keiser DJ, Crowley VM, Vialetto E, Mougiakos I, Wandera KG, Domgaard H, Weber J, Gaudin T, Metcalf J, Gray BN, Begemann MB, Jackson RN, Beisel CL (2023): Cas12a2 elicits abortive infection via RNA-triggered destruction of dsDNA. Nature, DOI: 10.1038/s41586-022-05559-3
https://www.nature.com/articles/s41586-022-05559-3

2.)
Bravo JPK, Hallmark T, Naegle B, Beisel CL, Jackson RN, Taylor DW (2023): Large-scale structural rearrangements unleash indiscriminate nuclease activity by CRISPR-Cas12a2. Nature, DOI: 10.1038/s41586-022-05560-w
https://www.nature.com/articles/s41586-022-05560-w

http://www.helmholtz-hzi.de

Media Contact

Susanne Thiele Presse und Kommunikation
Helmholtz-Zentrum für Infektionsforschung

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Future AR/VR controllers could be the palm of your hand

Carnegie Mellon University’s EgoTouch creates simple interfaces for virtual and augmented reality. The new generation of augmented and virtual reality controllers may not just fit in the palm of your…

‘Game changer’ in lithium extraction

Rice researchers develop novel electrochemical reactor. A team of Rice University researchers led by Lisa Biswal and Haotian Wang has developed an innovative electrochemical reactor to extract lithium from natural…

The blue-green sustainable proteins of seaweed

… may soon be on your plate. The protein in sea lettuce, a type of seaweed, is a promising complement to both meat and other current alternative protein sources. Seaweed…